Summary: A University of California San Diego study proposes that autism spectrum disorder (ASD) can arise when three conditions coincide during sensitive developmental windows: an inherited metabolic vulnerability, an early environmental trigger, and prolonged activation of the cell danger response (CDR). This “three-hit” metabolic signaling model reframes ASD as a disorder of disrupted cellular communication and energy metabolism, and suggests that many cases may be reduced or prevented through early screening and metabolic interventions.
The research integrates evidence from mitochondrial biology, immune signaling, and neural circuit development into a unified framework. By showing that two of the three contributing factors are potentially reversible, the model highlights opportunities for prenatal and early-life screening and interventions that could lower ASD risk or severity.
Key Facts
- Three biological contributors: inherited sensitivity, an early-life environmental trigger, and prolonged cellular stress interact to increase ASD risk.
- Metabolic signaling center stage: chronic purinergic (ATP-related) signaling and mitochondrial dysfunction can alter early neural circuit formation.
- Prevention and treatment potential: identifying and addressing metabolic stress in pregnancy or early infancy might reduce or prevent a large portion of cases.
Source: UCSD
Overview
A new study from UC San Diego School of Medicine presents a three-hit metabolic signaling model to explain how genetic predispositions and environmental exposures together can lead to ASD. Published in Mitochondrion, the model reframes autism as a neurometabolic and neuroimmune condition driven by interactions among inherited biochemical sensitivity, early-life triggers, and sustained activation of the cell danger response (CDR).
According to the model, autism emerges when the following align during critical periods spanning late pregnancy through the first two to three years of life:
- Genetic predisposition: inherited variants that sensitize mitochondria or ATP-triggered intracellular signaling pathways to environmental change.
- Early trigger: exposures such as maternal infection, early infant immune stress, or environmental pollution that activate the CDR.
- Prolonged activation: repeated or persistent exposures that keep the CDR active for months during a crucial window of neurodevelopment, interfering with normal brain circuit formation.
The CDR is a conserved metabolic response that helps cells heal and defend against threats. Normally it is temporary: cells enter the CDR to recover and then return to growth and development. When the CDR remains active—because of ongoing stressors or inherited hypersensitivity—it disrupts cellular signaling and mitochondrial function. A key mechanic is altered extracellular ATP (eATP) and purinergic signaling, which cells use to communicate stress. Chronic activation of these pathways can reshape how neural circuits develop, contributing to ASD traits.
“Behavior has a chemical basis,” said study author Robert K. Naviaux, M.D., Ph.D., professor of medicine, pediatrics and pathology at UC San Diego School of Medicine. “When the cell danger response stays on too long, the body diverts resources from normal growth to defense, leaving fewer resources for the developing brain.”
This systems-level framework connects many previously observed features of ASD—mitochondrial and immune dysfunction, microbiome alterations, and sensory differences—by showing how diverse stressors converge on shared metabolic and signaling pathways. The model explains why neither genes nor environment alone are invariably causative, but why certain combinations substantially increase risk.
Naviaux and colleagues emphasize prevention and early intervention because the second and third hits—the environmental triggers and sustained CDR—are potentially modifiable. Drawing an analogy to phenylketonuria (PKU), the authors note that strong genetic risks can still be managed effectively if identified and treated early. They estimate that targeted prenatal and newborn screening combined with early metabolic support might prevent or lessen approximately 40–50% of ASD cases in high-risk populations.
Proposed strategies include presymptomatic screening such as maternal metabolomic profiling, autoantibody testing, and specialized newborn analyses to identify children at greatest risk before behavioral symptoms emerge. The study also calls for development and clinical testing of antipurinergic therapies to normalize abnormal ATP signaling and for larger multisite trials of metabolic support approaches in children with ASD.
Naviaux advocates for integrated prenatal and early-life screening programs that combine genetics, metabolomics, and environmental data to detect and support at-risk families sooner. By focusing on the metabolic drivers of the CDR, researchers may be able to both prevent some cases and reduce the most disabling symptoms in others.
“Viewing autism through the lens of metabolic signaling changes both our understanding and our options,” Naviaux said. “If we can detect and calm the cellular stress response before it becomes chronic, we may be able to prevent or substantially reduce core impairments.”
Funding: The study received philanthropic support for the Naviaux Lab from multiple foundations, family funds, individual donors, and grassroots contributors. Early funding for the mass spectrometers used in the work was provided by Jane Botsford Johnson.
Conflict of interest: Naviaux has patents pending on the use of suramin and anti-purinergic therapies for ASD and serves on scientific advisory boards for several organizations and companies related to autism and metabolic research.
Key Questions Answered:
A: Genetic predisposition, an early environmental trigger, and prolonged activation of the cellular stress response.
A: Two of the three factors—environmental triggers and chronic cellular stress—are potentially reversible, making earlier intervention possible.
A: Chronic purinergic signaling and mitochondrial dysfunction can alter cellular communication and disrupt early brain-circuit formation, contributing to ASD symptoms.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full.
- Additional context was provided by staff to summarize the study’s implications.
About this autism research news
Author: Cindy Mam
Source: UCSD
Contact: Cindy Mam – UCSD
Image: Image credited to Neuroscience News
Original Research: Open access. “A 3-hit metabolic signaling model for the core symptoms of autism spectrum disorder” by Robert K. Naviaux. Mitochondrion
Abstract
A 3-hit metabolic signaling model for the core symptoms of autism spectrum disorder
This model describes three necessary contributors to ASD: (1) an inherited genotype that increases sensitivity of mitochondria and eATP-stimulated intracellular calcium signaling to environmental change; (2) early exposure to triggers that activate metabolic features of the cell danger response; and (3) recurrent or persistent exposure to CDR-activating triggers for at least three to six months during the critical neurodevelopmental window from the late first trimester through the first 18–36 months of life.
The three factors act functionally as primers, triggers, and amplifiers of the CDR. Because the CDR is governed by metabolic signaling, this framework links diverse ASD features under a common biochemical narrative. The PKU example illustrates that even strong genetic predispositions can be effectively managed when metabolic pathways are understood and modified. Since the second and third hits are adjustable, early detection and treatment before symptom onset may prevent some children from developing ASD, and interventions after diagnosis may substantially reduce core disabling symptoms.